newsfilter
← Latest News
GlobeNewswire·

CVRx to Present at the William Blair 46th Annual Growth Stock Conference

  • CVRx Inc. will present at the William Blair 46th Annual Growth Stock Conference in Chicago on June 2, 2026.
  • The management team presentation is scheduled to begin at 10:40 a.m. CT.
  • A live webcast of the event will be available at ir.cvrx.com.
  • An archived version of the presentation will be accessible at the same website for a limited time after the event.
  • CVRx is a commercial-stage company developing neuromodulation solutions for cardiovascular diseases.
  • The company's Barostim device is the first FDA-approved technology using neuromodulation to improve heart failure symptoms.
  • Barostim is an implantable device that delivers electrical pulses to baroreceptors in the carotid artery to balance the autonomic nervous system.
  • The device holds FDA Breakthrough Device designation & approval in the U.S.
  • Barostim has CE Mark approval for heart failure & resistant hypertension in the European Economic Area.